iHuman Statistics
Share Statistics
iHuman has 261.86M shares outstanding. The number of shares has increased by -11.55% in one year.
| Shares Outstanding | 261.86M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -11.35% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 77.86M |
| Failed to Deliver (FTD) Shares | 130 |
| FTD / Avg. Volume | 0.52% |
Short Selling Information
The latest short interest is 4.44K, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 4.44K |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 0.17 |
Valuation Ratios
The PE ratio is 6.73 and the forward PE ratio is 8.95.
| PE Ratio | 6.73 |
| Forward PE | 8.95 |
| PS Ratio | 1.2 |
| Forward PS | 0.1 |
| PB Ratio | 1.27 |
| P/FCF Ratio | 7.35 |
| PEG Ratio | n/a |
Enterprise Valuation
iHuman Inc. has an Enterprise Value (EV) of 7.90M.
| EV / Earnings | 0.04 |
| EV / Sales | 0.01 |
| EV / EBITDA | 0.05 |
| EV / EBIT | 0.05 |
| EV / FCF | 0.05 |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.
| Current Ratio | 2.82 |
| Quick Ratio | 2.78 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.19% and return on capital (ROIC) is 14.85%.
| Return on Equity (ROE) | 0.19% |
| Return on Assets (ROA) | 0.12% |
| Return on Capital (ROIC) | 14.85% |
| Revenue Per Employee | 1.30M |
| Profits Per Employee | 231.04K |
| Employee Count | 783 |
| Asset Turnover | 0.7 |
| Inventory Turnover | 17.97 |
Taxes
| Income Tax | 21.67M |
| Effective Tax Rate | 0.11 |
Stock Price Statistics
The stock price has increased by -37.68% in the last 52 weeks. The beta is 0.47, so iHuman 's price volatility has been higher than the market average.
| Beta | 0.47 |
| 52-Week Price Change | -37.68% |
| 50-Day Moving Average | 1.78 |
| 200-Day Moving Average | 1.77 |
| Relative Strength Index (RSI) | 48.78 |
| Average Volume (20 Days) | 25.08K |
Income Statement
In the last 12 months, iHuman had revenue of $1.02B and earned $180.91M in profits. Earnings per share was $3.3.
| Revenue | 1.02B |
| Gross Profit | 721.27M |
| Operating Income | 159.89M |
| Net Income | 180.91M |
| EBITDA | 171.58M |
| EBIT | 159.89M |
| Earnings Per Share (EPS) | 3.3 |
Balance Sheet
The company has $1.21B in cash and $3.86M in debt, giving a net cash position of $1.21B.
| Cash & Cash Equivalents | 1.21B |
| Total Debt | 3.86M |
| Net Cash | 1.21B |
| Retained Earnings | -140.46M |
| Total Assets | 1.36B |
| Working Capital | 847.97M |
Cash Flow
In the last 12 months, operating cash flow was $172.12M and capital expenditures -$6.51M, giving a free cash flow of $165.61M.
| Operating Cash Flow | 172.12M |
| Capital Expenditures | -6.51M |
| Free Cash Flow | 165.61M |
| FCF Per Share | 3.02 |
Margins
Gross margin is 70.84%, with operating and profit margins of 15.7% and 17.77%.
| Gross Margin | 70.84% |
| Operating Margin | 15.7% |
| Pretax Margin | 19.9% |
| Profit Margin | 17.77% |
| EBITDA Margin | 16.85% |
| EBIT Margin | 15.7% |
| FCF Margin | 16.27% |
Dividends & Yields
IH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 191.86% |
| FCF Yield | 184.38% |
Analyst Forecast
Currently there are no analyst rating for IH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.7 |
| Piotroski F-Score | 3 |